Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostatic Neoplasms, Castration-Resistant
Location: Dallas TX, Austin TX, The Woodlands TX, Houston TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07225946
Phase3, Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
for
Pulmonary Arterial Hypertension
Location: Dallas TX, Houston TX, San Antonio TX, Kansas City KS,
Sponsor: Gossamer Bio USA, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06274801
Phase3, Recruiting
A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
for
Renal Transplant Failure and Rejection
Location: Dallas TX, Atlanta GA, Tampa FL, Ann Arbor MI,
Sponsor: Nefro Avillion Clinical Development, LLC
Sex: All
Age: 18 - 70
Code: NCT07508787
Phase2, Recruiting
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Dallas TX, Wichita KS, Nashville TN, Iowa City IA,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT07439653
Phase1, Phase2, Recruiting
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Dallas TX, Aurora CO, Atlanta GA, Indianapolis IN,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Prospective Investigation of Cirrhotic Cardiomyopathy in Humans
for
Cirrhotic Cardiomyopathy
Location: Dallas TX, Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT07658222
Recruiting
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
for
Phenylketonuria
Location: Dallas TX
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 18 - 65
Code: NCT07477691
Recruiting
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
for
Sanfilippo Syndrome Type C
Location: Dallas TX
Sponsor: Phoenix Nest
Sex: All
Age: 1+
Code: NCT05825131
Recruiting
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
for
Homocystinuria
Location: Dallas TX, Atlanta GA, Phoenix AZ, Salt Lake City UT,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 12 - 65
Code: NCT06247085
Phase3, Recruiting
Late Onset Alzheimer's Disease
for
Alzheimer Disease
Location: Dallas TX, St Louis MO, Bloomington IN, Indianapolis IN,
Sponsor: Columbia University
Sex: All
Age: 55+
Code: NCT05010603
Recruiting
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
for
Generalized Lipodystrophy
Location: Dallas TX, Ann Arbor MI
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 2+
Code: NCT07220785
Phase3, Recruiting
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
for
Phase 1b, HC-7366, SHARK, Kidney Cancer
Location: Dallas TX, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07401875
Phase1, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Dallas TX, Oklahoma City OK, Houston TX, Fort Smith AR,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase3, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia